Skip to main content
Clinical Trials/NCT06137716
NCT06137716
Completed
Not Applicable

Development and Clinical Trials of a Rehabilitation Platform to Accelerate the Recovery of Patients With COVID Neuromotor Sequelae

University of Valladolid1 site in 1 country13 target enrollmentJuly 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Robotic Exoskeleton
Sponsor
University of Valladolid
Enrollment
13
Locations
1
Primary Endpoint
Barthel Index (BI)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Prolonged hospitalization in severe COVID-19 cases can lead to substantial muscle loss and functional deterioration. While rehabilitation is vital, conventional approaches encounter capacity constraints. Therefore, assessing the efficacy of robotic-assisted rehabilitation is crucial for post-COVID-19 fatigue syndrome patients, aiming to improve motor function and overall recovery. The study focuses on evaluating rehabilitation effectiveness in individuals with upper-extremity impairment using a hand exoskeleton-based robotic system.

Registry
clinicaltrials.gov
Start Date
July 1, 2022
End Date
February 1, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Juan Carlos Fraile

Professor

University of Valladolid

Eligibility Criteria

Inclusion Criteria

  • Over 30 years old
  • Patients infected with COVID-19 and has received care at the Centro Hospitalario Benito Menni
  • Patients with acute or limited functional or strength impairment in at least one of the upper extremities
  • Patients who would complete a rehabilitation program and a series of patient reported outcome questionnaires and a follow up evaluation
  • Patients who give inform written consent.

Exclusion Criteria

  • Presence of behavioral disorders
  • Dementia (loss of memory of cognitive functions)
  • Disorders of consciousness (confusional states and drowsiness)
  • Uncontrolled or severely limiting delusions and hallucinations
  • Infectious skin diseases
  • Rrisk of epileptic seizures due to COVID itself or prior to it
  • Severe visual impairments
  • Severe spasticity with a Modified Ashworth Scale \>2, joint stiffness in the wrist and fingers
  • Pain with a score \>8 on the Visual Analog Scale (VAS) during mobilization of the affected hand.

Outcomes

Primary Outcomes

Barthel Index (BI)

Time Frame: Baseline / 6 weeks

The Barthel Index (BI) modified by Granger et al is an ordinal scale for measuring the ability of an individual to independently execute 15 activities of daily living (ADL) related with mobility and self-care. BI aims to evaluate the degree of independence, with a final score ranging from 0 to 100, where 0 indicates full dependence.

Range of motion

Time Frame: Baseline / 6 weeks

The range of motion was analyzed by goniometry measurements using the HandTutor® glove. It provides the active and passive movement of the participants fingers through sensors located in the front and back of the glove.

Functional Independence Measure (MIF)

Time Frame: Baseline / 6 weeks

The Functional Independence Measure (MIF) was designed to provide an indicator of disability independent of a patient's impairment. The scale consists of 18 items to evaluate functional abilities in the area of communication, locomotion, self-care, social cognition, sphincter control and transfers. Each of these items is quantified utilizing a 7-point Likert scale. The total score, obtained by summing the individual item scores, spans from 18 to 126, with 18 denoting a state of complete dependence

SF-36 Health Questionnaire

Time Frame: Baseline / 6 weeks

The SF-36 Health Questionnaire consists of 36 items designed to assess health-related quality of live. It encompasses eight scales, each comprising 2 to 10 items, which aimed to evaluate various health attributes. These scales include physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional and mental health.The score of each scale ranges from 0 to 100, with higher scores indicating a better health-related quality of life.

Secondary Outcomes

  • Semi-structured interview(Baseline)

Study Sites (1)

Loading locations...

Similar Trials